Budweiser announced that it would follow Samuel Adam's lead of giving beer money to anyone who's gotten a coronavirus vaccine shot.
From now until May 16, beer drinkers who are 21 or older can go to ABeerOnBud.com and show their proof of vaccination, which is either a pic of your "I Got Vaccinated" sticker, a pic of the Band-Aid stuck to your upper arm, or a selfie taken while you were at a vaccination location.
The company will be giving away $5 debit cards to 10,000 people. However, residents of Alabama, California, and Texas aren't eligible to receive one.
For Sam Adams' beer giveaway, participants need to post a pic of their r sticker or bandage on Twitter or Instagram, tag @samadamsbeer, and use the hashtag #shotforsam to get $5 through Cash App to spend on brews.


Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates
One Percent Rule Checklist For Safer Forex Trading Risk
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 



